{
    "organizations": [],
    "uuid": "7c33923b40240ffa96a3eb2c6a665ec4be67540d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nuvo-pharma-acquires-us-product-ri/brief-nuvo-pharma-acquires-u-s-product-rights-to-resultz-from-piedmont-pharma-idUSASB0C0WE",
    "ord_in_thread": 0,
    "title": "BRIEF-Nuvo Pharma Acquires U.S. Product Rights To Resultz From Piedmont Pharma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 15 (Reuters) - Nuvo Pharmaceuticals Inc:\n* NUVO PHARMACEUTICALS (IRELAND) LIMITED ACQUIRES U.S. PRODUCT RIGHTS TO RESULTZ® FROM PIEDMONT PHARMACEUTICALS LLC\n* NUVO PHARMACEUTICALS INC - ‍UNDER TERMS OF AGREEMENT, $1.5 MILLION WAS PAID TO PIEDMONT FOR DEAL ON CLOSE USING EXISTING CASH ON HAND​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-15T21:26:00.000+02:00",
    "crawled": "2018-01-16T13:12:30.035+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "nuvo",
        "pharmaceutical",
        "inc",
        "nuvo",
        "pharmaceutical",
        "ireland",
        "limited",
        "acquires",
        "product",
        "right",
        "piedmont",
        "pharmaceutical",
        "llc",
        "nuvo",
        "pharmaceutical",
        "inc",
        "term",
        "agreement",
        "million",
        "paid",
        "piedmont",
        "deal",
        "close",
        "using",
        "existing",
        "cash",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}